Search Results

Agricola

Record details

Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia.

• Authors : Milic, Jovana; Novella, Alessio; Meschiari, Marianna

• Source: AIDS Research & Human Retroviruses; Apr2021, Vol. 37 Issue 4, p283-291, 9p

Record details

Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study.

• Authors : Elmekaty, Eman Zeyad I.; Alibrahim, Rim; Hassanin, Rania

Subjects: RITONAVIR; COVID-19; COVID-19 treatmentQATAR

• Source: PLoS ONE; 5/4/2022, Vol. 17 Issue 5, p1-14, 14p

Record details

Darunavir-Cobicistat versus Lopinavir-Ritonavir for COVID-19 Pneumonia: Qatar's Experience.

• Authors : Elmekaty, Eman Zeyad I.; Alibrahim, Rim; Hassanin, Rania

Subjects: CORONAVIRUS diseases; LOPINAVIR-ritonavir; COVID-19QATAR; CHINA

• Source: Journal of Emergency Medicine, Trauma & Acute Care; 2022, Vol. 2022 Issue 1, p1-3, 3p

Record details

Antiviral Activity and Safety of Darunavir/Cobicistat for the Treatment of COVID-19.

• Authors : Chen, Jun; Xia, Lu; Liu, Li

Subjects: COVID-19; POLYMERASE chain reaction; INTERFERON alphaSHANGHAI (China)

• Source: Open Forum Infectious Diseases; Jul2020, Vol. 7 Issue 7, p1-5, 5p

Record details

Study Design Characteristics and Pharmacological Mechanisms in International Clinical Trials Registry Platform: Registered Clinical Trials on Antiviral Drugs for COVID-19

• Authors : Zhang, Weilong; Lv, Yinghua; Yang, Juan

• Source: Drug Design, Development and Therapy. September 30, 2020, Vol. 14, p3803, 11 p.

Record details

Reply to: "Antiviral Activity and Safety of Darunavir/Cobicistat for Treatment of COVID-19".

• Authors : Nicolini, Laura Ambra; Mikulska, Malgorzata; Signori, Alessio

Subjects: COVID-19; CARDIOVASCULAR diseases

• Source: Open Forum Infectious Diseases; Aug2020, Vol. 7 Issue 8, p1-3, 3p

Record details

Delayed Clearance of Viral RNA in Sputum for Severity COVID-19 Patients with Initial High Viral Load.

• Authors : Zhao, Hong; Tu, Huilan; Yu, Xia

Subjects: COVID-19; VIRAL load; SPUTUM

• Source: Infection & Drug Resistance; Apr2022, Vol. 15, p1971-1979, 9p

Record details

SARS-CoV-2 Infection may be Prevented with Cytochrome Inhibitors: Cobicistat and Ritonavir.

• Authors : Çelik, İsmail¹; Gülten, Ezgi² ; Onay-Beşikci, Arzu³

Subjects: *COVID-19; *ANTIRETROVIRAL agents; *RITONAVIR

• Source: Infectious Diseases & Clinical Microbiology (IDCM). Sep2022, Vol. 4 Issue 3, p185-191. 7p.

Record details

Whole genome analysis and homology modeling of SARS-CoV-2 Indian isolate reveals potent FDA approved drug choice for treating COVID-19.

• Authors : Velu P; Department of Biotechnology and Biochemistry, Annamalai University, Chidambaram, Tamil Nadu, India.; Rathinavel T

Subjects: SARS-CoV-2* ; COVID-19*; Humans

• Source: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2023 Apr; Vol. 41 (7), pp. 2772-2788. Date of Electronic Publication: 2022 Feb 09.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details